abc biopply AG

abc biopply AG provides validated highly predictive preclinical CRO services for drug efficacy, safety, toxicity, resistance, and biomarker development based on its proprietary 3D CoSeedis humanized multi-organoid in chip technology™. The company provides validated and IND-relevant standard models (e.g. oncology, neurology, hepatic, obesity etc.) and based on its innovative NAM technology, development services for custom tailored study models with an out-licensing option for in-house implementation and scale up.